These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17996584)

  • 21. Management of relapsed and relapsed refractory myeloma.
    Kastritis E; Mitsiades CS; Dimopoulos MA; Richardson PG
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1175-215, x. PubMed ID: 17996594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lenalidomide in the treatment of multiple myeloma: a review.
    Armoiry X; Aulagner G; Facon T
    J Clin Pharm Ther; 2008 Jun; 33(3):219-26. PubMed ID: 18452408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Working the magic.
    Wallis L
    Nurs Stand; 2012 Jun 6-12; 26(40):61. PubMed ID: 22848973
    [No Abstract]   [Full Text] [Related]  

  • 24. Multiple myeloma: diagnosis and treatment.
    Nau KC; Lewis WD
    Am Fam Physician; 2008 Oct; 78(7):853-9. PubMed ID: 18841734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis.
    Slovacek L; Slovackova B; Pavlik V; Hrstka Z; Macingova Z; Jebavy L; Horacek JM
    Neoplasma; 2008; 55(4):350-5. PubMed ID: 18505348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [About the treatment of multiple myeloma].
    Hou J; Zhou LL
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):649-50. PubMed ID: 18399166
    [No Abstract]   [Full Text] [Related]  

  • 27. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
    Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
    Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple myeloma.
    Zulian GB; Babare R; Zagonel V
    Crit Rev Oncol Hematol; 1998 Feb; 27(2):165-7. PubMed ID: 9571324
    [No Abstract]   [Full Text] [Related]  

  • 29. Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens.
    van Marion AM; Auwerda JJ; Lisman T; Sonneveld P; de Maat MP; Lokhorst HM; Leebeek FW
    Leuk Res; 2008 Jul; 32(7):1078-84. PubMed ID: 18241919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of calcitonin in osteosclerosis of myeloma?
    Rousseau JJ; Heynen G; Franck G
    Arch Intern Med; 1980 Nov; 140(11):1554. PubMed ID: 7436658
    [No Abstract]   [Full Text] [Related]  

  • 31. Autologous stem-cell transplantation for multiple myeloma.
    Louw VJ; Louw H; Webb MJ
    N Engl J Med; 2009 Sep; 361(11):1118-9; author reply 1119. PubMed ID: 19741236
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of multiple myeloma in the targeted therapy era.
    Saad AA; Sharma M; Higa GM
    Ann Pharmacother; 2009 Feb; 43(2):329-38. PubMed ID: 19193585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated mucormycosis of an immunocompromised multiple myeloma patient: impact of biopsy of extramedullary tumours in refractory multiple myeloma.
    Gattenlöhner S; Unzicker C; Wörner S; Stuhler G; Einsele H; Müller-Hermelink HK
    Ann Hematol; 2009 Apr; 88(4):385-7. PubMed ID: 18758780
    [No Abstract]   [Full Text] [Related]  

  • 34. Disease and Symptom Care: A Focus on Specific Needs of Patients With Multiple Myeloma.
    Faiman B
    Clin J Oncol Nurs; 2017 Oct; 21(5 Suppl):3-6. PubMed ID: 28945733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential evaluation of serum hepcidin in anemic myeloma patients: study of correlations with myeloma treatment, disease variables, and anemia response.
    Katodritou E; Ganz T; Terpos E; Verrou E; Olbina G; Gastari V; Hadjiaggelidou C; Varthaliti M; Georgiadou S; Westerman M; Zervas K
    Am J Hematol; 2009 Aug; 84(8):524-6. PubMed ID: 19536845
    [No Abstract]   [Full Text] [Related]  

  • 36. Autologous or reduced-intensity conditioning allotransplantation for de novo multiple myeloma.
    Moreau P
    Bone Marrow Transplant; 2009 Apr; 43(7):591-2. PubMed ID: 18997831
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of multiple myeloma with diethylstilbestrol].
    REWALD E
    Prensa Med Argent; 1957 Aug; 44(34):2642-5. PubMed ID: 13518074
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of stilbamidine on multiple myeloma].
    FOIT R; SIEBEROVA-KLIMOVA R
    Cas Lek Cesk; 1952 Jan; 91(2):40-4. PubMed ID: 14390079
    [No Abstract]   [Full Text] [Related]  

  • 39. [Autologous stem cell transplantation in multiple myeloma - contra].
    Ludwig H
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1943. PubMed ID: 19760556
    [No Abstract]   [Full Text] [Related]  

  • 40. Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide.
    Srinivasan S; Schiffer CA
    Leuk Res; 2009 Apr; 33(4):561-4. PubMed ID: 18676017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.